Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Kolmert (Stockholm, Sweden), C. Gómez (Stockholm, Sweden), D. Lefaudeux (Lyon, France), B. De Meulder (Lyon, France), I. Pandis (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), P. Sterk (Amsterdam, Netherlands), I. Adcook (London, United Kingdom), B. Dahlén (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden). Baseline and longitudinal urinary eicosanoid profiles for molecular sub-phenotyping in the U-BIOPRED study. 3805

Member's Comments

No comment yet.

Related content which might interest you: Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Non-invasive urinary lipid mediator excretion profiles identify sub-phenotypes of asthma in the U-BIOPRED study Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Blood inflammatory patterns and dyspnea in asthmatics from the EGEA study: cross-sectional and longitudinal analyses Source: Annual Congress 2007 - Risk factors for prevalence and incidence of asthma Year: 2007 Prediction of longitudinal inflammatory phenotypes using baseline sputum transcriptomics in UBIOPRED Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Urinary metabolomics-profiling of the U-BIOPRED asthma study identified biochemical clusters associated with asthma severity Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 New approaches to tuberculosis diagnosis through the study of metabolomic profile in urine Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts Source: ERJ Open Res, 6 (4) 00320-2020; 10.1183/23120541.00320-2020 Year: 2020 Detailed physiological profiling of patients for a study investigating the airway microbiome Source: International Congress 2018 – Innovations in equipment and their application Year: 2018 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Metabolomics in the prediction of recurrent wheezing: a longitudinal healthy birth cohort study Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Late Breaking Abstract - Comparison of the blood transcriptomic profiles of adults and children from the U-BIOPRED asthma study Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma Year: 2017 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 The creation and long-term follow-up of a cohort of asthmatic patients. Baseline clinical characteristics of the study population: The MEGA Project: Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Novel patterns of serum biomarkers profiling using minimal important clinical outcomes (MICO) in the longidutinal study BODE cohort of COPD patients Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study Source: ERJ Open Res, 7 (3) 00243-2021; 10.1183/23120541.00243-2021 Year: 2021 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes Source: Eur Respir J 2014; 44: 985-993 Year: 2014